Review



chitligsan against pathogenic bacteria  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    ATCC chitligsan against pathogenic bacteria
    Characterisation of elemental composition and spectra of <t>Chitligsan.</t> (A) Constituent elements and EDS image patterns, (B) XRF results, and (C) FTIR spectra of Chitligsan.
    Chitligsan Against Pathogenic Bacteria, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 53092 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/chitligsan+against+pathogenic+bacteria/Escherichia+coli+(Migula)+Castellani+and+Chalmers/pmc12805422-53-9-16
    Average 99 stars, based on 53092 article reviews
    chitligsan against pathogenic bacteria - by Bioz Stars, 2026-10
    99/100 stars

    Images

    1) Product Images from "Sahara Desert sand “Chitligsan”: characterisation and assessment of antibacterial activity and cytotoxicity"

    Article Title: Sahara Desert sand “Chitligsan”: characterisation and assessment of antibacterial activity and cytotoxicity

    Journal: RSC Advances

    doi: 10.1039/d5ra04969e

    Characterisation of elemental composition and spectra of Chitligsan. (A) Constituent elements and EDS image patterns, (B) XRF results, and (C) FTIR spectra of Chitligsan.
    Figure Legend Snippet: Characterisation of elemental composition and spectra of Chitligsan. (A) Constituent elements and EDS image patterns, (B) XRF results, and (C) FTIR spectra of Chitligsan.

    Techniques Used:

    Analysis of the XRD patterns of Chitligsan. Calcite was the most abundant mineral (42.8%), followed by hydrotalcite (40.3%), clinopyroxene 15.6%, and ilmenite 1.3%.
    Figure Legend Snippet: Analysis of the XRD patterns of Chitligsan. Calcite was the most abundant mineral (42.8%), followed by hydrotalcite (40.3%), clinopyroxene 15.6%, and ilmenite 1.3%.

    Techniques Used:

    Gas chromatography of volatile compounds generated from pyrolysis of chitosan standard (black trace) and Chitligsan (blue trace).
    Figure Legend Snippet: Gas chromatography of volatile compounds generated from pyrolysis of chitosan standard (black trace) and Chitligsan (blue trace).

    Techniques Used: Gas Chromatography, Generated

    Proposed formation mechanism of Chitligsan. Desert sand minerals (Fe 2 O 3 , FeOOH) interact with oxalic acid and light, promoting Fe( iii )/Fe( ii ) redox cycling through chelation and partial reduction under light and moisture, leading to the formation of the mineral composite Chitligsan.
    Figure Legend Snippet: Proposed formation mechanism of Chitligsan. Desert sand minerals (Fe 2 O 3 , FeOOH) interact with oxalic acid and light, promoting Fe( iii )/Fe( ii ) redox cycling through chelation and partial reduction under light and moisture, leading to the formation of the mineral composite Chitligsan.

    Techniques Used:

    Antibacterial activities of Chitligsan samples, prepared with distilled water and 0.1 M citric acid, against E. coli (ATCC 25922), S. aureus (ATCC 29213), and P. aeruginosa (ATCC 27853). Supernatant: supernatant of Chitligsan suspension, blank: distilled water (DI), ciprofloxacin (CIP) (5 µg mL −1 ), 1: Chitligsan DI extract (1 mg mL −1 ), 2: 0.1 M citric acid (control), 3: Chitligsan 0.1 M citric acid extract (1 mg mL −1 ).
    Figure Legend Snippet: Antibacterial activities of Chitligsan samples, prepared with distilled water and 0.1 M citric acid, against E. coli (ATCC 25922), S. aureus (ATCC 29213), and P. aeruginosa (ATCC 27853). Supernatant: supernatant of Chitligsan suspension, blank: distilled water (DI), ciprofloxacin (CIP) (5 µg mL −1 ), 1: Chitligsan DI extract (1 mg mL −1 ), 2: 0.1 M citric acid (control), 3: Chitligsan 0.1 M citric acid extract (1 mg mL −1 ).

    Techniques Used: Suspension, Control

    SEM micrographs illustrating the morphological changes of S. aureus (A–C) and E. coli (D–F) upon exposure to Chitligsan or citric acid. (A and D) Untreated control cells; (B and E) cells treated with 0.1 M citric acid; (C and F) cells treated with Chitligsan (1 mg mL −1 ) and 0.1 M citric acid.
    Figure Legend Snippet: SEM micrographs illustrating the morphological changes of S. aureus (A–C) and E. coli (D–F) upon exposure to Chitligsan or citric acid. (A and D) Untreated control cells; (B and E) cells treated with 0.1 M citric acid; (C and F) cells treated with Chitligsan (1 mg mL −1 ) and 0.1 M citric acid.

    Techniques Used: Control

    MTT assay results for L929 cells after 24 h of exposure to serial dilutions (50 mg mL −1 , 25 mg mL −1 , 12.5 mg mL −1 , 6.25 mg mL −1 ) of Chitligsan stock solution (100 mg mL −1 ). N = 3, * p < 0.05; ** p < 0.01. Control: untreated cells. Positive control (cytotoxic agent): 2.5% DMSO.
    Figure Legend Snippet: MTT assay results for L929 cells after 24 h of exposure to serial dilutions (50 mg mL −1 , 25 mg mL −1 , 12.5 mg mL −1 , 6.25 mg mL −1 ) of Chitligsan stock solution (100 mg mL −1 ). N = 3, * p < 0.05; ** p < 0.01. Control: untreated cells. Positive control (cytotoxic agent): 2.5% DMSO.

    Techniques Used: MTT Assay, Control, Positive Control

    Scratch assay results for L929 cells after 48 h of exposure to Chitligsan (100 mg mL −1 ). Quantification of scratch closure at 24 h and 48 h relative to 0 h in control and Chitligsan-treated groups. The scale bar in the images represents 100 µm. Control: untreated cells. Quantitative analysis of scratch closure (%) at 24 h and 48 h relative to 0 h. (A) Quantification of scratch closure at 24 h and 48 h relative to 0 h, (B) Representative phase-contrast images of scratch wounds at 0 h, 24 h, and 48 h.
    Figure Legend Snippet: Scratch assay results for L929 cells after 48 h of exposure to Chitligsan (100 mg mL −1 ). Quantification of scratch closure at 24 h and 48 h relative to 0 h in control and Chitligsan-treated groups. The scale bar in the images represents 100 µm. Control: untreated cells. Quantitative analysis of scratch closure (%) at 24 h and 48 h relative to 0 h. (A) Quantification of scratch closure at 24 h and 48 h relative to 0 h, (B) Representative phase-contrast images of scratch wounds at 0 h, 24 h, and 48 h.

    Techniques Used: Wound Healing Assay, Control

    Related Articles

    Activity Assay:

    Article Title: Sahara Desert sand “Chitligsan”: characterisation and assessment of antibacterial activity and cytotoxicity
    Article Snippet: .. In addition to physicochemical examination, the antibacterial activity of Chitligsan against pathogenic bacteria ( Escherichia coli ATCC 25922, Pseudomonas aeruginosa ATCC 27853, and Staphylococcus aureus ATCC 29213), alongside its cytotoxicity and impact on cell viability, was evaluated to gain further insight into its compatibility with biological systems. ..

    Bacteria:

    Article Title: Sahara Desert sand “Chitligsan”: characterisation and assessment of antibacterial activity and cytotoxicity
    Article Snippet: .. In addition to physicochemical examination, the antibacterial activity of Chitligsan against pathogenic bacteria ( Escherichia coli ATCC 25922, Pseudomonas aeruginosa ATCC 27853, and Staphylococcus aureus ATCC 29213), alongside its cytotoxicity and impact on cell viability, was evaluated to gain further insight into its compatibility with biological systems. ..



    Similar Products

    99
    ATCC chitligsan against pathogenic bacteria
    Characterisation of elemental composition and spectra of <t>Chitligsan.</t> (A) Constituent elements and EDS image patterns, (B) XRF results, and (C) FTIR spectra of Chitligsan.
    Chitligsan Against Pathogenic Bacteria, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/chitligsan+against+pathogenic+bacteria/Escherichia+coli+(Migula)+Castellani+and+Chalmers/pmc12805422-53-9-16
    Average 99 stars, based on 1 article reviews
    chitligsan against pathogenic bacteria - by Bioz Stars, 2026-10
    99/100 stars
      Buy from Supplier

    Image Search Results


    Characterisation of elemental composition and spectra of Chitligsan. (A) Constituent elements and EDS image patterns, (B) XRF results, and (C) FTIR spectra of Chitligsan.

    Journal: RSC Advances

    Article Title: Sahara Desert sand “Chitligsan”: characterisation and assessment of antibacterial activity and cytotoxicity

    doi: 10.1039/d5ra04969e

    Figure Lengend Snippet: Characterisation of elemental composition and spectra of Chitligsan. (A) Constituent elements and EDS image patterns, (B) XRF results, and (C) FTIR spectra of Chitligsan.

    Article Snippet: In addition to physicochemical examination, the antibacterial activity of Chitligsan against pathogenic bacteria ( Escherichia coli ATCC 25922, Pseudomonas aeruginosa ATCC 27853, and Staphylococcus aureus ATCC 29213), alongside its cytotoxicity and impact on cell viability, was evaluated to gain further insight into its compatibility with biological systems.

    Techniques:

    Analysis of the XRD patterns of Chitligsan. Calcite was the most abundant mineral (42.8%), followed by hydrotalcite (40.3%), clinopyroxene 15.6%, and ilmenite 1.3%.

    Journal: RSC Advances

    Article Title: Sahara Desert sand “Chitligsan”: characterisation and assessment of antibacterial activity and cytotoxicity

    doi: 10.1039/d5ra04969e

    Figure Lengend Snippet: Analysis of the XRD patterns of Chitligsan. Calcite was the most abundant mineral (42.8%), followed by hydrotalcite (40.3%), clinopyroxene 15.6%, and ilmenite 1.3%.

    Article Snippet: In addition to physicochemical examination, the antibacterial activity of Chitligsan against pathogenic bacteria ( Escherichia coli ATCC 25922, Pseudomonas aeruginosa ATCC 27853, and Staphylococcus aureus ATCC 29213), alongside its cytotoxicity and impact on cell viability, was evaluated to gain further insight into its compatibility with biological systems.

    Techniques:

    Gas chromatography of volatile compounds generated from pyrolysis of chitosan standard (black trace) and Chitligsan (blue trace).

    Journal: RSC Advances

    Article Title: Sahara Desert sand “Chitligsan”: characterisation and assessment of antibacterial activity and cytotoxicity

    doi: 10.1039/d5ra04969e

    Figure Lengend Snippet: Gas chromatography of volatile compounds generated from pyrolysis of chitosan standard (black trace) and Chitligsan (blue trace).

    Article Snippet: In addition to physicochemical examination, the antibacterial activity of Chitligsan against pathogenic bacteria ( Escherichia coli ATCC 25922, Pseudomonas aeruginosa ATCC 27853, and Staphylococcus aureus ATCC 29213), alongside its cytotoxicity and impact on cell viability, was evaluated to gain further insight into its compatibility with biological systems.

    Techniques: Gas Chromatography, Generated

    Proposed formation mechanism of Chitligsan. Desert sand minerals (Fe 2 O 3 , FeOOH) interact with oxalic acid and light, promoting Fe( iii )/Fe( ii ) redox cycling through chelation and partial reduction under light and moisture, leading to the formation of the mineral composite Chitligsan.

    Journal: RSC Advances

    Article Title: Sahara Desert sand “Chitligsan”: characterisation and assessment of antibacterial activity and cytotoxicity

    doi: 10.1039/d5ra04969e

    Figure Lengend Snippet: Proposed formation mechanism of Chitligsan. Desert sand minerals (Fe 2 O 3 , FeOOH) interact with oxalic acid and light, promoting Fe( iii )/Fe( ii ) redox cycling through chelation and partial reduction under light and moisture, leading to the formation of the mineral composite Chitligsan.

    Article Snippet: In addition to physicochemical examination, the antibacterial activity of Chitligsan against pathogenic bacteria ( Escherichia coli ATCC 25922, Pseudomonas aeruginosa ATCC 27853, and Staphylococcus aureus ATCC 29213), alongside its cytotoxicity and impact on cell viability, was evaluated to gain further insight into its compatibility with biological systems.

    Techniques:

    Antibacterial activities of Chitligsan samples, prepared with distilled water and 0.1 M citric acid, against E. coli (ATCC 25922), S. aureus (ATCC 29213), and P. aeruginosa (ATCC 27853). Supernatant: supernatant of Chitligsan suspension, blank: distilled water (DI), ciprofloxacin (CIP) (5 µg mL −1 ), 1: Chitligsan DI extract (1 mg mL −1 ), 2: 0.1 M citric acid (control), 3: Chitligsan 0.1 M citric acid extract (1 mg mL −1 ).

    Journal: RSC Advances

    Article Title: Sahara Desert sand “Chitligsan”: characterisation and assessment of antibacterial activity and cytotoxicity

    doi: 10.1039/d5ra04969e

    Figure Lengend Snippet: Antibacterial activities of Chitligsan samples, prepared with distilled water and 0.1 M citric acid, against E. coli (ATCC 25922), S. aureus (ATCC 29213), and P. aeruginosa (ATCC 27853). Supernatant: supernatant of Chitligsan suspension, blank: distilled water (DI), ciprofloxacin (CIP) (5 µg mL −1 ), 1: Chitligsan DI extract (1 mg mL −1 ), 2: 0.1 M citric acid (control), 3: Chitligsan 0.1 M citric acid extract (1 mg mL −1 ).

    Article Snippet: In addition to physicochemical examination, the antibacterial activity of Chitligsan against pathogenic bacteria ( Escherichia coli ATCC 25922, Pseudomonas aeruginosa ATCC 27853, and Staphylococcus aureus ATCC 29213), alongside its cytotoxicity and impact on cell viability, was evaluated to gain further insight into its compatibility with biological systems.

    Techniques: Suspension, Control

    SEM micrographs illustrating the morphological changes of S. aureus (A–C) and E. coli (D–F) upon exposure to Chitligsan or citric acid. (A and D) Untreated control cells; (B and E) cells treated with 0.1 M citric acid; (C and F) cells treated with Chitligsan (1 mg mL −1 ) and 0.1 M citric acid.

    Journal: RSC Advances

    Article Title: Sahara Desert sand “Chitligsan”: characterisation and assessment of antibacterial activity and cytotoxicity

    doi: 10.1039/d5ra04969e

    Figure Lengend Snippet: SEM micrographs illustrating the morphological changes of S. aureus (A–C) and E. coli (D–F) upon exposure to Chitligsan or citric acid. (A and D) Untreated control cells; (B and E) cells treated with 0.1 M citric acid; (C and F) cells treated with Chitligsan (1 mg mL −1 ) and 0.1 M citric acid.

    Article Snippet: In addition to physicochemical examination, the antibacterial activity of Chitligsan against pathogenic bacteria ( Escherichia coli ATCC 25922, Pseudomonas aeruginosa ATCC 27853, and Staphylococcus aureus ATCC 29213), alongside its cytotoxicity and impact on cell viability, was evaluated to gain further insight into its compatibility with biological systems.

    Techniques: Control

    MTT assay results for L929 cells after 24 h of exposure to serial dilutions (50 mg mL −1 , 25 mg mL −1 , 12.5 mg mL −1 , 6.25 mg mL −1 ) of Chitligsan stock solution (100 mg mL −1 ). N = 3, * p < 0.05; ** p < 0.01. Control: untreated cells. Positive control (cytotoxic agent): 2.5% DMSO.

    Journal: RSC Advances

    Article Title: Sahara Desert sand “Chitligsan”: characterisation and assessment of antibacterial activity and cytotoxicity

    doi: 10.1039/d5ra04969e

    Figure Lengend Snippet: MTT assay results for L929 cells after 24 h of exposure to serial dilutions (50 mg mL −1 , 25 mg mL −1 , 12.5 mg mL −1 , 6.25 mg mL −1 ) of Chitligsan stock solution (100 mg mL −1 ). N = 3, * p < 0.05; ** p < 0.01. Control: untreated cells. Positive control (cytotoxic agent): 2.5% DMSO.

    Article Snippet: In addition to physicochemical examination, the antibacterial activity of Chitligsan against pathogenic bacteria ( Escherichia coli ATCC 25922, Pseudomonas aeruginosa ATCC 27853, and Staphylococcus aureus ATCC 29213), alongside its cytotoxicity and impact on cell viability, was evaluated to gain further insight into its compatibility with biological systems.

    Techniques: MTT Assay, Control, Positive Control

    Scratch assay results for L929 cells after 48 h of exposure to Chitligsan (100 mg mL −1 ). Quantification of scratch closure at 24 h and 48 h relative to 0 h in control and Chitligsan-treated groups. The scale bar in the images represents 100 µm. Control: untreated cells. Quantitative analysis of scratch closure (%) at 24 h and 48 h relative to 0 h. (A) Quantification of scratch closure at 24 h and 48 h relative to 0 h, (B) Representative phase-contrast images of scratch wounds at 0 h, 24 h, and 48 h.

    Journal: RSC Advances

    Article Title: Sahara Desert sand “Chitligsan”: characterisation and assessment of antibacterial activity and cytotoxicity

    doi: 10.1039/d5ra04969e

    Figure Lengend Snippet: Scratch assay results for L929 cells after 48 h of exposure to Chitligsan (100 mg mL −1 ). Quantification of scratch closure at 24 h and 48 h relative to 0 h in control and Chitligsan-treated groups. The scale bar in the images represents 100 µm. Control: untreated cells. Quantitative analysis of scratch closure (%) at 24 h and 48 h relative to 0 h. (A) Quantification of scratch closure at 24 h and 48 h relative to 0 h, (B) Representative phase-contrast images of scratch wounds at 0 h, 24 h, and 48 h.

    Article Snippet: In addition to physicochemical examination, the antibacterial activity of Chitligsan against pathogenic bacteria ( Escherichia coli ATCC 25922, Pseudomonas aeruginosa ATCC 27853, and Staphylococcus aureus ATCC 29213), alongside its cytotoxicity and impact on cell viability, was evaluated to gain further insight into its compatibility with biological systems.

    Techniques: Wound Healing Assay, Control